Related Experiment Video

Updated: Jun 23, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

Patient preferences and satisfaction with systemic therapies for psoriasis: an area to be explored

L L A Lecluse, J L E Tutein Nolthenius, J D Bos

    The British Journal of Dermatology
    |May 7, 2009
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Measuring Psoriasis Severity at Home
    02:28

    Measuring Psoriasis Severity at Home

    Published on: March 1, 2024

    Related Experiment Videos

    Last Updated: Jun 23, 2026

    The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
    11:39

    The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

    Published on: July 11, 2013

    Measuring Psoriasis Severity at Home
    02:28

    Measuring Psoriasis Severity at Home

    Published on: March 1, 2024

    Related Concept Videos

    Modified-Release Drug Delivery Systems: Site-Targeted01:24

    Modified-Release Drug Delivery Systems: Site-Targeted

    Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
    Factors Affecting Drug Response: Overview01:21

    Factors Affecting Drug Response: Overview

    When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...

    Articles linked to this work by shared authors, journal, and citation graph.

    International consensus on dose reduction of biologics for patients with psoriasis: The DR. Delphi study.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2026

    Baseline characteristics of atopic eczema patients enrolled in seven European registries united in the TREatment of ATopic eczema (TREAT) registry taskforce.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2025

    The Eczema Area and Severity Index: An update of progress and challenges in its measurement of atopic dermatitis after 20 years of use.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2024

    Real-world reported adverse events related to systemic immunomodulating therapy in patients with atopic dermatitis: Results from the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2023

    Phototherapy for atopic dermatitis: A survey of European practice.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2023

    Implementation of the HOME core outcome set for clinical trials of atopic eczema-barriers and opportunities: the HOME IX meeting report.

    Archives of dermatological research·2023

    Paper Mills in Dermatology: A Cross-Sectional Study of Retracted Publications.

    The British journal of dermatology·2026

    Distinct genotype-phenotype patterns in non-syndromic hereditary hypotrichosis: a multicenter Chinese cohort.

    The British journal of dermatology·2026

    Efficacy and Safety of Recibokibart, an Interleukin-36 Receptor Antibody, in Generalized Pustular Psoriasis: A Phase 2 Randomized Trial.

    The British journal of dermatology·2026

    Remote identification of new onset pediatric atopic dermatitis - a comparison of diagnostic methods from a post-hoc analysis of the CASCADE prevention trial.

    The British journal of dermatology·2026

    Factors Influencing Physician Prescribing Practices for Overactive Bladder Pharmacotherapy: A Systematic Review.

    Neurourology and urodynamics·2026

    Optimizing efficacy to safety ratio of glucocorticoids in rheumatoid arthritis models by leveraging PPARα agonism.

    Arthritis & rheumatology (Hoboken, N.J.)·2026

    Effect of obesity on pharmacokinetics and drug dosing of remimazolam in patients with obstructive sleep apnoea.

    Anaesthesia·2026

    Dose Exploration Based on Quantitative Pharmacokinetic Analysis of Monoclonal Antibodies for Pediatric Immune-Mediated Diseases: Current Evidence and Future Directions.

    Drug design, development and therapy·2026

    Association Between CYP450 Polymorphisms and Treatment Outcomes of Escitalopram and Venlafaxine in Patients with Post Stroke Depression.

    Neuropsychiatric disease and treatment·2026

    A Physiologically-Based Pharmacokinetic Model to Predict Posaconazole Suspension Exposure and Optimize Dosing Strategy in Pediatric Hematology Patients: Incorporating the Impact of Food Intake.

    Drug design, development and therapy·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us